Which are the causes of Pigmented villonodular synovitis?

TL;DR: Pigmented villonodular synovitis (PVNS), now more accurately termed tenosynovial giant cell tumor (TGCT), is a rare, benign, locally aggressive tumor of the synovium caused by a specific genetic translocation that leads to the overproduction of colony-stimulating factor 1 (CSF-1). While the exact "root cause" of why this mutation occurs remains unknown, it is not considered an inherited or autoimmune disease, but rather a neoplastic process driven by cellular signaling errors.

What causes Pigmented villonodular synovitis?

At the biological level, Pigmented villonodular synovitis is driven by a chromosomal translocation involving the CSF1 gene. Think of the synovium—the lining of your joints—like a garden. In a healthy joint, the cells grow in a regulated, orderly fashion. In Pigmented villonodular synovitis, a specific genetic "mishap" (a translocation between chromosomes 1 and 2) causes the cells to produce an excessive amount of a protein called colony-stimulating factor 1 (CSF-1). This protein acts like a hyperactive fertilizer, causing the synovial cells to multiply uncontrollably and form the tumor masses characteristic of the disease.

Is Pigmented villonodular synovitis a genetic or hereditary condition?

It is important to distinguish between "genetic" and "hereditary." While Pigmented villonodular synovitis is caused by a genetic mutation, it is not hereditary. You do not inherit it from your parents, and you cannot pass it on to your children. The mutation occurs sporadically in a single cell within the joint lining during a person's lifetime. Because this change is "somatic" (occurring in the body’s cells rather than the germline), it is not encoded in your DNA that you were born with.

What are the risk factors and environmental triggers?

Currently, there are no known environmental triggers, lifestyle choices, or dietary factors that cause Pigmented villonodular synovitis. Researchers have looked for links to previous joint trauma or injury, but while many patients report a past injury to the affected joint, there is no definitive clinical evidence proving that trauma causes the tumor. It is more likely that the symptoms of the tumor (such as swelling or locking) lead patients to recall a past injury, rather than the injury causing the tumor itself.

What does current research tell us about the etiology?

The medical community has shifted its understanding of Pigmented villonodular synovitis from an inflammatory condition to a neoplastic (tumor-like) process. Current research is focused on the following areas:

• CSF-1 Signaling: Understanding how the overproduction of CSF-1 recruits other inflammatory cells to the tumor site, creating a "microenvironment" that supports tumor growth.


• Targeted Therapies: Because we know the tumor is driven by the CSF-1 pathway, researchers are testing CSF-1 receptor inhibitors (like pexidartinib) to "turn off" the growth signal.


• Molecular Diagnosis: Using advanced genetic sequencing to confirm the diagnosis of Pigmented villonodular synovitis by identifying the specific CSF1 translocation, which helps distinguish it from other joint conditions.

With 31 members currently sharing their experiences on DiseaseMaps.org, we see firsthand how this condition impacts daily life, underscoring the need for continued research into these complex cellular mechanisms.

Next steps

• Consult an orthopedic oncologist or a rheumatologist with specific experience in synovial tumors.


• Request a referral for advanced imaging, such as an MRI, which is the gold standard for visualizing the extent of Pigmented villonodular synovitis.


• Join the DiseaseMaps.org community to connect with others navigating the complexities of this diagnosis.


• Ask your physician about clinical trials investigating targeted systemic therapies if surgery is not a viable or sufficient option.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Tenosynovial Giant Cell Tumor.


• Orphanet: Pigmented villonodular synovitis.


• OMIM (Online Mendelian Inheritance in Man): Tenosynovial Giant Cell Tumor.


• Journal of the American Academy of Orthopaedic Surgeons: "Current Concepts in Tenosynovial Giant Cell Tumor."